Genius Properties Ltd.: Reiva Submitted Six Product Licence Applications to the Natural Health Product Directorate (NHPD)

MONTREAL, QUEBEC--(Marketwired - June 17, 2015) - Genius Properties Ltd. (the"Corporation") (CSE:GNI) is proud to announce that it has achieved one of its key milestones for the commercialization of its Reïva brand product line.

According to Dr Guy Chamberland, M.Sc., Ph.D., the person responsible for product development for Reïva, the company has completed the development of six natural novel health products to be sold under the Reïva brand. These products target conditions, such as sexual health, muscle recovery process associated with a resistance training regimen, enhancing physical capacity/performance, supporting cardiovascular health, etc.

These products adhere to the corporation's vision of commercializing products that are natural and healthy, that can be used by athletes and or the health minded consumer. Some are innovative products for adults and others can be safely used by both adolescents and adults. According to Dr Chamberland, the ingredients used by Reïva are backed by strong clinical trial data brining a new dimension to this competitive market.

The company submitted six Product Licence Applications to the Natural Health Product Directorate (NHPD). NHPD issued an Application Acknowledgement Letter for each product after completing an examination for administrative completeness. This is the first step leading to the approval of the products. The Reïva brand products will now undergo a review for safety, efficacy and quality in accordance with the review policies established by NHPD.

About Reïva

Reïva has developed a range of world class exclusive products, a "next generation" of natural and functional beverages and related products. Its founder's primary objective is to offer a healthier lifestyle to consumers. When Denis Richard started developing world class exclusive formulas, he addressed the problems at their source, in collaboration with universities and independent laboratories. The Reïva team is committed to producing safe and efficient products designed to fill the void in the industry by offering consumers products focused on health and wellness. The team's devotion is supported by several pending patent applications.

Reïva Global Corp. aims markets with high sales volumes, such as:

• The energy drinks market (37 billion dollars in 2014);

• The sports nutrition supplements market (4.2 billion dollars in 2014);

• The energy bars market (more than one billion dollars in 2014);

• The children's healthy snacks market.

The "REÏVA" products include the following features:

• They have a first choice antioxidant power;

• They greatly improve sports performances;

• They improve blood circulation;

• They improve control on good and bad cholesterol;

• They have recognized cardiovascular features;

• They are high quality dietary supplements;

• They help the body metabolize carbohydrates, fats and proteins;

• They help maintain good muscular functions;

• They help the regeneration of red blood cells;

• They reinforce the immune system;

• And much more.

About Genius

Genius is an international firm dedicated to building, buying, investing, and representing the next generation of brands. We focus on selecting and marketing brands that are innovative, eco-friendly, and/or are market disruptors. We only work with brands that have scalable revenue potential.

A Proven Team and Formula

• Ensures systems are in place to conduct business

• Provides the execution strategy for launching brands

• Develops powerful presentations for launch of products

• Creates marketing programs that are affordable but look like tier 1 companies

• Build national and international sales teams to successfully launch products with great potential

This news release contains forward-looking information within the meaning of applicable Canadian securities laws. All information other than historical fact is forward-looking information. Forward-looking information relates to future events or future performance and is based on Genius' current internal expectations, estimates, projections, assumptions and beliefs. Forward-looking information is often, but not always, identified by the use of words such as "expect", "project", "proposed", "intend", "seek", "anticipate", "budget", "plan", "continue", "estimate", "forecast", "may", "will", "predict", "potential", "targeting", "could", "might", "should", "believe" and similar expressions. Although management considers the assumptions and estimates, reflected in forward-looking information, to be reasonable, based on information currently available, there can be no assurance that such information will prove to be correct. As a consequence, actual results may differ materially from those anticipated.

Undue reliance should not be placed on forward-looking information which is inherently uncertain, and subject to known and unknown risks and uncertainties (both general and specific) and other factors that contribute to the possibility that the future events or circumstances contemplated by the forward looking information will not occur or that may cause the actual results, level of activity, performance or achievements of the Corporation to be materially different from those expressed or implied by such forward-looking information. These risks include, but are not limited to risks associated with general economic conditions, the actual results of current exploration activities, conclusions of economic evaluations, changes in project parameters as plans continue to be refined, future metal prices, financial risks and substantial capital requirements. Further information regarding certain of these risks (as well as risks relating generally to the Corporation's business) may be found under the headings "Risks and Uncertainties", "Forward-Looking Information" and "Financial risk factors" in the latest Corporation's Management's Discussion & Analysis on www.sedar.com. Readers are cautioned that the foregoing list of factors that may affect future results is not exhaustive. The forward-looking statements contained in this news release are made as of the date hereof and Genius does not undertake any obligation to update publicly or to revise any of the included forward-looking statements, except as required by applicable law. The forward-looking statements contained herein are expressly qualified by this cautionary statement.

The CSE has neither approved nor disapproved the contents of this press release. Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.